In a notice of interest published on February 18, the agency outlined the types of study proposals it hopes to fund and gave instructions to researchers on how to apply.
Of course, even as NIDA encourages this kind of research, the head of the agency has repeatedly recognized that marijuana’s status as a Schedule I drug makes the application process onerous.
Several federal health agencies have worked to bolster cannabis science as the legalization movement spreads.